Microorganisms with claimed probiotic properties: An overview of recent literature

International Journal of Environmental Research and Public Health

Volumn 11, Issue 5, 2014, Pages 4745-4767

  Fijan, Sabina ^a  

^a UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Bacillus; Bifidobacterium; Enterococcus; Escherichia coli; Lactic acid bacteria; Lactobacillus; Leuconostoc; Pediococcus; Saccharomyces; Streptococcus

Indexed keywords

PROBIOTIC AGENT;

BACTERIUM; MICROORGANISM; PROBIOTICS; RISK ASSESSMENT; SAFETY;

BACILLUS; BACILLUS CEREUS; BACILLUS COAGULANS; BACILLUS SUBTILIS; BACTERIAL CLEARANCE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM INFANTIS; CLOSTRIDIUM DIFFICILE INFECTION; CONSTIPATION; DIARRHEA; ECZEMA; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ENTEROCOLITIS; ESCHERICHIA COLI; HELICOBACTER PYLORI; HOMEOSTASIS; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SAKEI; LACTOBACILLUS SALIVARIUS; LACTOCOCCUS LACTIS; LACTOSE INTOLERANCE; NONHUMAN; REVIEW; RISK BENEFIT ANALYSIS; SACCHAROMYCES; SACCHAROMYCES BOULARDII; SAFETY; STRAIN IDENTIFICATION; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; BACTERIAL INFECTIONS; BACTERIAL PHENOMENA AND FUNCTIONS; HUMAN; MICROBIOLOGY; RISK ASSESSMENT; SPECIES DIFFERENCE;

BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGICAL PHENOMENA; HUMANS; PROBIOTICS; RISK ASSESSMENT; SPECIES SPECIFICITY;

EID: 84899887430     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110504745     Document Type: Review

References (175)

1. Gruber, I.; Heudorf, U.; Werner, G.; Pfeifer, Y.; Imirzalioglu, C.; Ackermann, H.; Brandt, C.; Besier, S.; Wichelhaus, T.A. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care-prevalence and risk factors. Int. J. Med. Microbiol. 2013, 303, 405-409.
2. Fijan, S.; Šostar-Turk, S. Hospital textiles, are they a possible vehicle for healthcare-associated infections? Int. J. Environm. Res. Public Health 2012, 9, 3330-3343.
3. NIH HMP Working group; Peterson, J.; Garges, S.; Giovanni, M.; McInnes, P.; Wang, L.; Schloss, J.A.; Bonazzi, V.; McEwen, J.E.; Wetterstrand, K.A.; et al. The NIH Human Microbiome Project. Genome Res. 2009, 19, 2317-2323.
4. Relman, D.A. New technologies, human-microbe interactions, and the search for previously unrecognized pathogens. J. Infect. Dis. 2002,186, S254-S258.
5. Relman, D.A.; Falkow, S. The meaning and impact of the human genome sequence for microbiology. Trends. Microbiol. 2001, 9, 206-208.
6. Savage, D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977, 31, 107-133.
7. Vieira, A.; Teixeira, M.M.; Martins, F.S. The role of probiotics and prebiotics in inducing gut immunity. Front. Immunol. 2012, 4, 445, doi:10.3389/fimmu.2013.00445.
8. Ubeda, C.; Pamer, E.G. Antibiotics, microbiota, and immune defense. Trends Immunol. 2012, 33, 459-466.
9. Ramakrishna, B.S. Role of the gut microbiota in human nutrition and metabolism. J. Gastroenterol. Hepatol. 2013, 4, 9-17.
10. Specter, M. Germs are us. Bacteria make us sick. Do they also keep us alive? New Yorker 2012, 22, 32-39.
11. Food and Agriculture Organization of the United Nations/World Health Organization FAO/WHO. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. 2001. Available online: http://www.who.int/foodsafety/publications/ fs_management/en/probiotics.pdf (accessed on 20 January 2014).
12. Food and Agriculture Organization of the United Nations/World Health Organization FAO/WHO. Guidelines for the Evaluation of Probiotics in Food; Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food: London, Ontario, Canada, 2002.
13. Guidance on the Implementation of Regulation N81924/2006 on Nutrition and Health Claims Made on Foods. Conclusions of the Standing Committee on the Food Chain and Animal Health. Available online: http://ec.europa.eu/food/food/labellingnutrition/claims/guidance_claim_14-12- 07.pdf (accessed on 20 January 2014).
14. Rijkers, G.T.; De Vos, W.M.; Brummer, R.J.; Morelli, L.; Corthier, G.; Marteau, P. Health benefits and health claims of probiotics: Bridging science and marketing. Br. J. Nutr. 2011, 106, 1291-1296.
15. Reid, G. Microbiology: Categorize probiotics to speed research. Nature 2012, 485, 446, doi:10.1038/485446a.
16. Mackowiak, P.A. Recycling metchnikoff: Probiotics, the intestinal microbiome and the quest for long life. Front. Public Health. 2013, 1, 52, doi:10.3389/fpubh.2013.00052.
17. Didari, T.; Solki, S.; Mozaffari, S.; Nikfar, S.; Abdollahi, M. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014, 13, 227-239.
18. Azais-Braesco, V.; Bresson, J.L.; Guarner, F.; Corthier, G. Not all lactic acid bacteria are probiotics, but some are. Br. J. Nutr. 2010, 103, 1079-1081.
19. Conway, P.L.; Gorbach, S.L.; Goldin, B.R. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 1987, 70, 1-12.
20. Tulumoglu, S.; Yuksekdag, Z.N.; Beyatli, Y.; Simsek, O.; Cinar, B.; Yaşar, E. Probiotic properties of Lactobacilli species isolated from children's feces. Anaerobe 2013, 24, 36-42.
21. Sarkar, S. Approaches for enhancing the viability of probiotics: A review. Br. Food J. 2010, 112, 329-349.
22. Seale, J.V.; Millar, M. Probiotics: A new frontier for infection control. J. Hosp. Inf. 2013, 84, 1-4.
23. Anwar, A.A.; Thikra, A.A.; Saeed, A.M. Adhesion, autoaggregation and hydrophobicity of six Lactobacillus strains. Br. Microbiol. Res. J. 2014, 4, 381-391.
24. Ganguly, N.K.; Bhattacharya, S.K.; Sesikeran, B.; Nair G.B.; Ramakrishna, B.S.; Sachdev, H.P.S.; Batish, V.K.; Kanagasabapathy, A.S.; Muthuswamy, V.; Kathuria, S.C. et al. ICMR-DBT guidelines for evaluation of probiotics in food. Indian J. Med. Res. 2011, 134, 22-25.
25. Makarova, K.; Slesarev, A.; Wolf, Y.; Sorokin, A.; Mirkin, B.; Koonin, E.; Pavlov, A.; Pavlova, N.; Karamychev, V.; Polouchine, N. et al. Comparative genomics of the lactic acid bacteria. Proc. Natl. Acad. Sci. USA 2006, 103, 15611-15616.
26. Walter, J. Ecological role of Lactobacilli in the gastrointestinal tract: Implications for fundamental and biomedical research. Appl. Environ. Microbiol. 2008, 74, 4985-4996.
27. Walker, W.A. Initial intestinal colonization in the human infant and immune homeostasis. Ann. Nutr. Metab. 2013, 63, 8-15.
28. Siragusa, S.; De Angelis, M.; Calasso, M.; Campanella, D.; Minervini, F.; Di Cagno, R.; Gobbetti, M. Fermentation and proteome profiles of Lactobacillus plantarum strains during growth under food-like conditions. J. Proteomics. 2013, 96, 366-380.
29. De Vuyst, L.; Van Kerrebroeck, S.; Harth, H.; Huys, G.; Daniel, H.M.; Weckx, S. Microbial ecology of sourdough fermentations: Diverse or uniform? Food Microbiol. 2014, 37, 11-29.
30. Bauer, R.; du Toit, M.; Kossmann, J. Influence of environmental parameters on production of the acrolein precursor 3-hydroxypropionaldehyde by Lactobacillus reuteri DSMZ 20016 and its accumulation by wine Lactobacilli. Int. J. Food Microbiol. 2010, 137, 28-31.
31. Compare, D.; Nardone, G. The role of gut microbiota in the pathogenesis and management of allergic diseases. Eur. Rev. Med. Pharmacol. Sci. 2013, 17, 11-17.
32. Taverniti, V.; Scabiosi, C.; Arioli, S.; Mora, D.; Guglielmetti, S. Short-term daily intake of 6 billion live probiotic cells can be insufficient in healthy adults to modulate the intestinal bifidobacteria and Lactobacilli. J. Funct. Foods. 2013, 6, 482-491.
33. Johnston, B.C.; Goldenberg, J.Z.; Vandvik, P.O.; Sun, X.; Guyatt, G.H. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev. 2011, 11, CD004827, doi: 10.1002/14651858.CD004827.pub2.
34. Hempel, S.; Newberry, S.J.; Maher, A.R.; Wang, Z.; Miles, J.N.; Shanman, R.; Johnsen, B.; Shekelle, P.G. Probiotics for the prevention and treatment of antibiotic- associated diarrhea: A systematic review and meta-analysis. JAMA 2012, 307, 1959-1969.
35. Lee, S.J.; Bose, S.; Seo, J.G.; Chung, W.S.; Lim, C.Y.; Kim, H. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trial. Clin. Nutr. 2013, doi:10.1016/j.clnu.2013.12.006.
36. Ruiz, L.; Margolles, A.; Sánchez, B. Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front Microbiol. 2013, 4, 396, doi:10.3389/fmicb.2013.00396.
37. Zelaya, H.; Tsukida, K.; Chiba, E.; Marranzino, G.; Alvarez, S.; Kitazawa, H.; Agüero, G.; Villena, J. Immunobiotic Lactobacilli reduce viral-associated pulmonary damage through the modulation of inflammation-coagulation interactions. Int. Immunopharmacol. 2014, 19, 161-173.
38. Grin, P.M.; Kowalewska, P.M.; Alhazzan, W.; Fox-Robichaud, A.E. Lactobacillus for preventing recurrent urinary tract infections in women: Meta-analysis. Can. J. Urol. 2013, 20, 6607-6614.
39. McFarland, L.V. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med. Infect. Dis. 2007, 5, 97-105.
40. Senok, A.C.; Verstraelen, H.; Temmerman, M.; Botta, G.A. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev. 2009, 7, CD006289, doi:10.1002/14651858.CD006289.pub2.
41. Dugoua, J.J.; Machado, M.; Zhu, X.; Chen, X.; Koren, G.; Einarson, T.R. Probiotic safety in pregnancy: A systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J. Obstet. Gynaecol. Can. 2009, 31, 542-552.
42. Doron, S.I.; Hibberd, P.L.; Gorbach, S.L. Probiotics for prevention of antibiotic-associated diarrhea. J. Clin. Gastroenterol. 2008, 42, S58-S63.
43. Chmielewska, A.; Szajewska, H. Systematic review of randomised controlled trials: Probiotics for functional constipation. World J. Gastroenterol. 2010, 16, 69-75.
44. Ahmed, J.; Reddy, B.S.; Mølbak, L.; Leser, T.D.; MacFie J. Impact of probiotics on colonic microflora in patients with colitis: A prospective double blind randomised crossover study. Int. J. Surg. 2013, 11, 1131-1136.
45. Rautio, M.; Jousimies-Somer, H.; Kauma, H.; Pietarinen, I.; Saxelin, M.; Tynkkynen, S.; Koskela, M. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin. Infect. Dis. 1999, 28, 1159-1160.
46. Mackay, A.D.; Taylor, M.B.; Kibbler, C.C.; Hamilton-Miller, J.M.T. Lactobacillus endocarditis caused by a probiotic organism. Clin. Microbiol. Infect. 1999, 5, 290-292.
47. Chen, J.; Cai, W.; Feng, Y. Development of intestinal bifidobacteria and Lactobacilli in breast-fed neonates. Clin Nutr. 2007, 26, 559-566.
48. Noriega, L.; Cuevas, I.; Margolles, A.; de los Reyes-Gavilán, C.G. Deconjugation and bile salts hydrolase activity by Bifidobacterium strains with acquired resistance to bile. Int. Dairy J. 2006, 16, 850-855.
49. Dylag, K.; Hubalewska-Mazgaj, M.; Surmiak, M.; Szmyd, J.; Brzozowski, T. Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Curr. Pharm. Des. 2014, 20, 1149-1155.
50. Aloisio, I.; Santini, C.; Biavati, B.; Dinelli, G.; Cencič, A.; Chingwaru, W.; Mogna, L.; Di Gioia, D. Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns. Appl. Microbiol. Biotechnol. 2012, 96, 561-576.
51. Di Gioia, D.; Aloisio, I.; Mazzola, G.; Biavati, B. Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants. Appl. Microbiol. Biotechnol. 2014, 98, 563-577.
52. Demers, M.; Dagnault, A.; Desjardins, J.A. Randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin. Nutr. 2013, doi:10.1016/j.clnu.2013.10.015.
53. Isolauri, E.; Rautava, S.; Salminen, S. Probiotics in the development and treatment of allergic disease. Gastroenterol. Clin. North. Am. 2012, 41, 747-762.
54. Witthuhn, R.C.; Schoeman, T., Britz, T.J. Characterisation of the microbial population at different stages of Kefir production and Kefir grain mass cultivation. Int. Dairy J. 2005, 15, 383-389.
55. Marsh, A.J.; O'Sullivan, O.; Hill, C.; Ross, R.P.; Cotter, P.D. Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples. Food Microbiol. 2014, 38, 171-178.
56. Dinleyici, E.C.; Eren, M.; Ozen, M.; Yargic, Z.A.; Vandenplas, Y. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin. Biol. Ther. 2012, 12, 395-410.
57. Shan, L.S.; Hou, P.; Wang, Z.J.; Liu, F.R.; Chen, N.; Shu, L.H.; Zhang, H.; Han, X.H.; Han, X.X.; Cai, X.X. et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef. Microbes. 2013, 1, 329-334.
58. Szajewska, H.; Mrukowicz, J. Meta-analysis: Non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol. Ther. 2005, 22, 365-372.
59. Choi, C.H.; Jo, S.Y.; Park, H.J.; Chang, S.K.; Byeon, J.S.; Myung, S.J. A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: Effect on quality of life. J. Clin. Gastroenterol. 2011, 45, 679-683.
60. Guslandi, M.; Mezzi, G.; Sorghi, M.; Testoni, P.A. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig. Dis. Sci. 2000, 45, 1462-1464.
61. Guslandi, M.; Giollo, P.; Testoni, P.A. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 2003, 15, 697-698.
62. Fitzpatrick, L.R. Probiotics for the treatment of Clostridium difficile associated disease. World J. Gastrointest. Pathophysiol. 2013, 4, 47-52.
63. Thygesen, J.B.; Glerup, H.; Tarp B. Saccharomyces boulardii fungemia caused by treatment with a probioticum. BMJ Case. Rep. 2012, doi:10.1136/bcr.06.2011.4412.
64. Hennequin, C.; Kauffmann-Lacroix, C.; Jobert, A.; Viard, J.P.; Ricour, C.; Jacquemin, J.L.; Berche, P. Possible role of catheters in Saccharomyces boulardii fungemia. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19, 16-20.
65. Yang, X.; Wang, Y.; Huo, G. Complete Genome Sequence of Lactococcus lactis subsp. lactis KLDS4.0325. Genome Announc. 2013, 1, doi:10.1128/genomeA.00962-13.
66. Gao, Y.; Lu, Y.; Teng, K.L.; Chen, M.L.; Zheng, H.J.; Zhu, Y.Q.; Zhong, J. Complete genome sequence of Lactococcus lactis subsp. lactis CV56, a probiotic strain isolated from the vaginas of healthy women. J. Bacteriol. 2011, 193, 2886-2887.
67. Hossain, Z. Bacteria: Streptococcus. Encyclop. Food Safety 2014, 1, 535-545.
68. Hadji-Sfaxi, I.; El-Ghaish, S.; Ahmadova, A.; Batdorj, B.; Le Blay-Laliberté, G.; Barbier, G.; Haertlé, T.; Chobert, J.M. Antimicrobial activity and safety of use of Enterococcus faecium PC4.1 isolated from Mongol yogurt. Food Contr. 2011, 22, 2020-2027.
69. Liaskovs'ky and T.M.; Pidhors'ky and V.S.; Kovalenko, N.K.; Harmasheva, I.L.; Muchnyk, F.V. Identification of probiotic lactic acid bacteria strains. Mikrobiol Z. 2008, 70, 3-9.
70. Pieniz, S.; Andreazza, R.; Pereira, J.Q.; de Oliveira Camargo, F.A.; Brandelli, A. Production of selenium-enriched biomass by Enterococcus durans. Biol Trace. Elem. Res. 2013, 155, 447-454
71. Dirienzo D.B. Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets. Nutr Rev. 2014, 72, 18-29.
72. Bednorz C.; Guenther, S.; Oelgeschläger, K.; Kinnemann, B.; Pieper, R.; Hartmann, S.; Tedin, K.; Semmler, T.; Neumann, K.; Schierack, P.; Bethe, A.; Wieler, L.H. Feeding the probiotic Enterococcus faecium strain NCIMB 10415 to piglets specifically reduces the number of Escherichia coli pathotypes that adhere to the gut mucosa. Appl. Environ. Microbiol. 2013, 79, 7896-7904.
73. Cao, G.T.; Zeng, X.F.; Chen, A.G.; Zhou, L.; Zhang, L.; Xiao, Y.P.; Yang, C.M. Effects of a probiotic, Enterococcus faecium, on growth performance, intestinal morphology, immune response, and cecal microflora in broiler chickens challenged with Escherichia coli K88. Poult. Sci. 2013, 92, 2949-2955.
74. Larsen, N.; Thorsen, L.; Kpikpi, E.N.; Stuer-Lauridsen, B.; Cantor, M.D.; Nielsen, B.; Brockmann, E.; Derkx, P.M.; Jespersen, L. Characterization of Bacillus spp. strains for use as probiotic additives in pig feed. Appl. Microbiol. Biotechnol. 2013, doi:10.1007/s00253-013-5343-6.
75. Zokaeifar, H.; Babaei, N.; Saad, C.R.; Kamarudin, M.S.; Sijam, K.; Balcazar, J.L. Administration of Bacillus subtilis strains in the rearing water enhances the water quality, growth performance, immune response, and resistance against Vibrio harveyi infection in juvenile white shrimp, Litopenaeus vannamei. Fish Shellfish Immunol. 2014, 36, 68-74.
76. Tompkins, T.A.; Xu, X.; Ahmarani, J.A. comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation. Benef. Microbes. 2010, 1, 93-106.
77. Oggioni, M.R.; Pozzi, G.; Balensin, P.E.; Galieni, P.; Bigazzi, C. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J. Clin. Microbiol. 1998, 36, 325-326.
78. Richard, V.; Auwera, P.; Snoeck, R.; Daneau, D.; Meunier, F. Nosocomial bacteremia caused by Bacillus species. Eur. J. Clin. Microbiol. Infect. Dis. 1988, 7, 783-785.
79. Hosoi, T.; Hirose, R.; Saegusa, S.; Ametani, A.; Kiuchi, K.; Kaminogawa, S. Cytokine responses of human intestinal epithelial-like Caco-2 cells to the nonpathogenic bacterium Bacillus subtilis (natto). Int. J. Food Microbiol. 2003, 82, 255-264.
80. Trapecar, M.; Leouffre, T.; Faure, M.; Jensen, H.E.; Granum, P.E.; Cencic, A.; Hardy, S.P. The use of a porcine intestinal cell model system for evaluating the food safety risk of Bacillus cereus probiotics and the implications for assessing enterotoxigenicity. APMIS 2011, 119, 877-884.
81. Kamar, R.; Gohar, M.; Jéhanno, I.; Réjasse, A.; Kallassy, M.; Lereclus, D.; Sanchis, V.; Ramarao, N.J. Pathogenic potential of Bacillus cereus strains as revealed by phenotypic analysis. Clin. Microbiol. 2013, 51, 320-323.
82. Spinosa, M.R.; Wallet, F.; Courcol, R.J.; Oggioni, M.R. The trouble in tracing opportunistic pathogens: Cholangitis due to Bacillus in a French hospital caused by a strain related to an Italian probiotic? Microb. Ecol. Health Dis. 2000, 12, 99-101.
83. Behnsen, J.; Deriu, E.; Sassone-Corsi, M.; Raffatellu, M. Probiotics: Properties, examples, and specific applications. Cold Spring Harb. Perspect. Med. 2013, 3, doi:10.1101/cshperspect.a010074.
84. Xia, P.; Zhu, J.; Zhu, G. Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy-A review. Acta Microbiol. Sin. 2013, 53, 538-544.
85. Savard, P.; Lamarche, B.; Paradis, M.E.; Thiboutot, H.; Laurin, E.; Roy, D. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Int. J. Food Microbiol. 2011, 149, 50-57.
86. Gueimonde, M.; Salminen, S. Microbiota of the Intestine: Probiotics. Encyclopedia of Human Nutrition, 3rd ed.; Elsevier: Amsterdam, The Netherlands, 2013; pp. 175-181.
87. Goldenberg, J.Z.; Ma, S.S.; Saxton, J.D.; Martzen, M.R.; Vandvik, P.O.; Thorlund, K.; Guyatt, G.H.; Johnston, B.C. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013, 5, doi:10.1002/14651858.CD006095.pub3.
88. Guthmann, F.; Kluthe, C.; Buhrer, C. Probiotics for prevention of necrotising enterocolitis: An updated metaanalysis. Klin. Padiatr. 2010, 222, 284-290.
89. Bernardo, W.M.; Aires, F.T.; Carneiro, R.M.; Sá, F.P.; Rullo, V.E.; Burns, D.A. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: A systematic review and meta-analysis. J. Pediatr (Rio. J.) 2013, 89, 18-24.
90. AlFaleh, K.; Anabrees, J. Efficacy and safety of probiotics in preterm infants. J. Neonatal. Perinat. Med. 2013, 6, 1-9.
91. Wong, J.M.; de Souza, R.; Kendall, C.W.; Emam, A.; Jenkins, D.J. Colonic health: Fermentation and short chain fatty acids. J. Clin. Gastroent. 2006, 40, 235-243.
92. Wilhelm, S.M.; Johnson, J.L.; Kale-Pradhan, P.B. Treating bugs with bugs: The role of probiotics as adjunctive therapy for Helicobacter pylori. Ann Pharmacother. 2011, 45, 960-966.
93. Hemsworth, J.C.; Hekmat, S.; Reid, G. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes. 2012, 3, 414-419.
94. Enos, M.K.; Burton, J.P.; Dols, J.; Buhulata, S.; Changalucha, J.; Reid, G. Probiotics and nutrients for the first 1000 days of life in the developing world. Benef Microbes. 2013, 4, 3-16.
95. Serban, D.E. Gastrointestinal cancers: Influence of gut microbiota, probiotics and prebiotics. Cancer Lett. 2013, 345, 258-270.
96. Orlando, A.; Russo, F. Intestinal microbiota, probiotics and human gastrointestinal cancers. J. Gastrointest. Cancer. 2013, 44, 121-131.
97. Kmonickova, E.; Kverka, M.; Tlaskalová-Hogenová, H.; Kostecka, P.; Zidek, Z. Stimulation of nitric oxide, cytokine and prostaglandin production by low-molecular weight fractions of probiotic Lactobacillus casei lysate. Neuro Endocrinol Lett. 2012, 33, 166-172.
98. Boyle, R.J.; Bath-Hextall, F.J.; Leonardi-Bee, J.; Murell, D.F.; Tang, M.L. Probiotics for the treatment of eczema: A systematic review. Clin. Exp. Alergy. 2009, 39, 1117-1127.
99. Azad, M.B.; Coneys, J.G.; Kozyrskyj, A.L.; Field, C.J.; Ramsey, C.D.; Becker, A.B.; Friesen, C.; Abou-Setta, A.M.; Zarychanski, R. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: Systematic review and meta-analysis. BMJ 2013, 347, doi: 10.1136/bmj.f6471.
100. Elazab, N.; Mendy, A.; Gasana, J.; Vieira, E.R.; Quizon, A.; Forno, E. Probiotic administration in early life, atopy, and asthma: A meta-analysis of clinical trials. Pediatrics 2013, 132, e666-e676.
101. Pedroso, A.A.; Hurley-Bacon, A.L.; Zedek, A.S.; Kwan, T.W.; Jordan, A.P.; Avellaneda, G.; Hofacre, C.L.; Oakley, B.B.; Collett, S.R.; Maurer, J.J.; Lee, M.D. Can probiotics improve the environmental microbiome and resistome of commercial poultry production? Int. J. Environ. Res. Public. Health. 2013, 10, 4534-4559.
102. Punaro, G.R.; Maciel, F.R.; Rodrigues, A.M.; Rogero, M.M.; Bogsan, C.S.; Oliveira, M.N.; Ihara, S.S.; Araujo, S.R.; Sanches, T.R.; Andrade, L.C. et al. Kefir administration reduced progression of renal injury in STZ-diabetic rats by lowering oxidative stress. Nitric Oxide. 2014, 37, 53-60.
103. Liang, S.; Webb, T.; Li, Z. Probiotic antigens stimulate hepatic natural killer T cells. Immunol. 2014, 141, 203-210.
104. Newaj-Fyzul, A.; Al-Harbi, A.H.; Austin B. Review: Developments in the use of probiotics for disease control in aquaculture. Aquacult. 2013, doi:10.1016/j.aquaculture.2013.08.026.
105. Besselink, M.G.; van Santvoort, H.C.; Buskens, E.; Boermeester, M.A.; van Goor, H.; Timmerman, H.M.; Nieuwenhuijs, V.B.; Bollen, T.L.; van Ramshorst, B.; Witteman, B.J.; et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371, 651-659.
106. Hooijmans, C.R.; de Vries, R.B.; Rovers, M.M.; Gooszen, H.G.; Ritskes-Hoitinga, M. The effects of probiotic supplementation on experimental acute pancreatitis: A systematic review and meta-analysis. PLoS One 2012, 7, doi:10.1371/journal.pone.0048811.
107. McClave, S.A.; Heyland, D.K.; Wischmeyer, P.E. Comment on: Probiotic prophylaxis in predicted severe acute pancreatitis: A randomized, double-blind, placebo-controlled trial. J. Parenter Enteral Nutr. 2009, 33, 444-446.
108. Foolad, N.; Armstrong, A.W. Prebiotics and probiotics: The prevention and reduction in severity of atopic dermatitis in children. Benef. Microbes. 2014, doi:10.3920/BM2013.0034.
109. Licciardi, P.V.; Ismail, I.H.; Balloch, A.; Mui, M.; Hoe, E.; Lamb, K.; Tang, M.L. Maternal supplementation with LGG reduces vaccine-specific immune responses in infants at high-risk of developing allergic disease. Front. Immunol. 2013, 4, doi:10.3389/fimmu.2013.00381.
110. Wickens, K.; Stanley, T.V.; Mitchell, E.A.; Barthow, C.; Fitzharris, P.; Purdie, G.; Siebers, R.; Black, P.N.; Crane, J. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: Does it also reduce atopic sensitization? Clin. Exp. Allergy. 2013, 43, 1048-1057.
111. Panwar, H.; Calderwood, D.; Grant, I.R.; Grover, S.; Green, B.D. Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential. Eur. J. Nutr. 2014, doi: 10.1007/s00394-013-0649-9.
112. Jakaitis, B.M.; Denning, P.W. Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses. Pathophysiology 2014, 21, 47-54.
113. Homayouni, A.; Bastani, P.; Ziyadi, S.; Mohammad-Alizadeh-Charandabi, S.; Ghalibaf, M.; Mortazavian, A.M.; Mehrabany, E.V. Effects of probiotics on the recurrence of bacterial vaginosis: A review. J. Low Genit. Tract. Dis. 2014, 18, 79-86.
114. Sanchez, M.; Darimont, C.; Drapeau, V.; Emady-Azar, S.; Lepage, M.; Rezzonico, E.; Ngom-Bru, C.; Berger, B.; Philippe, L.; Ammon-Zuffrey, C. et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br. J. Nutr. 2013, 111, 1507-1519.
115. Ciccarelli, S.; Stolfi, I.; Caramia, G. Management strategies in the treatment of neonatal and pediatric gastroenteritis. Infect. Drug Resist. 2013, 6, 133-161.
116. Luoto, R.; Ruuskanen, O.; Waris, M.; Kalliomäki, M.; Salminen, S.; Isolauri, E. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: A randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2013, 133, 405-413.
117. Ammoscato, F.; Scirocco, A.; Altomare, A.; Matarrese, P.; Petitta, C.; Ascione, B.; Caronna, R.; Guarino, M.; Marignani, M.; Cicala, M. et al. Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage. Neurogastroenterol. Motil. 2013, doi:10.1111/nmo.12232.
118. Phavichitr, N.; Puwdee, P.; Tantibhaedhyangkul, R. Cost-benefit analysis of the probiotic treatment of children hospitalized for acute diarrhea in Bangkok, Thailand. Southeast Asian J. Trop. Med. Public Health 2013, 44, 1065-1071.
119. Cortés-Zavaleta, O.; López-Malo, A.; Hernández-Mendoza, A.; García, H.S. Antifungal activity of Lactobacilli and its relationship with 3-phenyllactic acid production. Int. J. Food. Microbiol. 2014, 173, 30-35.
120. Mohseni, M.J.; Aryan, Z.; Emamzadeh-Fard, S.; Paydary, K.; Mofid, V.; Joudaki, H.; Kajbafzadeh, A.M. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iran. J. Pediatr. 2013, 23, 430-438.
121. Ortiz, L.; Ruiz, F.; Pascual, L.; Barberis, L. Effect of two probiotic strains of Lactobacillus on in vitro adherence of Listeria monocytogenes, Streptococcus agalactiae, and Staphylococcus aureus to vaginal epithelial cells. Curr. Microbiol. 2014, doi:10.1007/s00284-014-0524-9.
122. Wu, Z.J.; DU, X.; Zheng, J. Role of Lactobacillus in the prevention of Clostridium difficile-associated diarrhea: A meta-analysis of randomized controlled trials. Chin. Med. J. (Engl.) 2013, 126, 4154-4161.
123. Kovachev, S.; Dobrevski-Vacheva, R. [Effect of Lactobacillus casei var. rhamnosus (Gynophilus) in restoring the vaginal flora by female patients with bacterial vaginosis-Randomized, open clinical trial]. Akush. Ginekol. (Sofiia) 2013, 52 (Suppl. 1), 48-53.
124. Wright, K.; Wright, H.; Murray, M. Probiotic treatment for the prevention of antibiotic-associated diarrhoea in geriatric patients: A multicentre randomised controlled pilot study. Australas. J. Ageing 2014, doi:10.1111/ajag.12116.
125. Shida, K.; Nomoto, K. Probiotics as efficient immunopotentiators: Translational role in cancer prevention. Indian J. Med. Res. 2013, 138, 808-814.
126. Vaghef-Mehrabany, E.; Alipour, B.; Homayouni-Rad, A.; Sharif, S.K.; Asghari-Jafarabadi, M.; Zavvari, S. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 2013, 30, 430-435.
127. Castillo, N.A.; de Moreno de LeBlanc, A.; Galdeano, C.M.; Perdigón, G. Comparative study of the protective capacity against Salmonella infection between probiotic and nonprobiotic Lactobacilli. J. Appl. Microbiol. 2013, 114, 861-876.
128. Noto Llana, M.; Sarnacki, S.H.; Aya Castañeda Mdel, R.; Bernal, M.I.; Giacomodonato, M.N.; Cerquetti, M.C. Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL-23/IL-17 expression. PLoS One 2013, 10,doi:10.1371/journal.pone.0082588.
129. Babenko, L.R.; Lazarenko, L.M.; Shynkarenko, L.M.; Mokrozub, V.V.; Pidgorskyi, V.S.; Spivak, M.J. The effect of Lacto- and Bifidobacteria in monoculture on the vaginal microflora in norm and in cases of intravaginal staphylococcosis. Mikrobiol. Z. 2013, 75, 46-55.
130. Qin, Y.; Li, J.; Wang, Q.; Gao, K.; Zhu, B.; Lv, N. [Identification of lactic acid bacteria in commercial yogurt and their antibiotic resistance]. Acta Microbiol. Sin. 2013, 53, 889-897.
131. Moro-García, M.A.; Alonso-Arias, R.; Baltadjieva, M.; Fernández Benítez, C.; Fernández Barrial, M.A.; Díaz Ruisánchez, E.; Alonso Santos, R.; Alvarez Sánchez, M.; Saavedra Miján, J.; López-Larrea, C. Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects. Age (Dordr) 2013, 35, 1311-1326.
132. Abedi, D.; Feizizadeh, S.; Akbari, V.; Jafarian-Dehkordi, A. In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli. Res. Pharm. Sci. 2013, 8, 260-268.
133. Tillisch, K.; Labus, J.; Kilpatrick, L.; Jiang, Z.; Stains, J.; Ebrat, B.; Guyonnet, D.; Legrain-Raspaud, S.; Trotin, B.; Naliboff, B.; Mayer, E.A. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013, 144, 1394-1401.
134. Suzuki, S.; Yakabe, T.; Suganuma, H.; Fukao, M.; Saito, T.; Yajima, N. Cell-bound exopolysaccharides of Lactobacillus brevis KB290: protective role and monosaccharide composition. Can. J. Microbiol. 2013, 59, 549-555.
135. Campus, G.; Cocco, F.; Carta, G.; Cagetti, M.G.; Simark-Mattson, C.; Strohmenger, L.; Lingström, P. Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren. Clin. Oral Investig. 2014, 18, 555-561.
136. Fujimura, K.E.; Demoor, T.; Rauch, M.; Faruqi, A.A.; Jang, S.; Johnson, C.C.; Boushey, H.A.; Zoratti, E.; Ownby, D.; Lukacs, N.W. et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc. Natl. Acad. Sci. USA 2014, 111, 805-810.
137. Hsieh, P.S.; Tsai, Y.C.; Chen, Y.C.; The, S.F.; Ou, C.M.; King, V.A. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32. Helicobacter 2012, 17, 466-477.
138. Zhang, Y.C.; Zhang, L.W.; Ma, W.; Yi, H.X.; Yang, X.; Du, M.; Shan, Y.J.; Han, X.; Zhang, L.L. Screening of probiotic Lactobacilli for inhibition of Shigella sonnei and the macromolecules involved in inhibition. Anaerobe 2012, 18, 498-503.
139. Lue, K.H.; Sun, H.L.; Lu, K.H.; Ku, M.S.; Sheu, J.N.; Chan, C.H.; Wang, Y.H. A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12 years. Int. J. Pediatr. Otorhinolaryngol. 2012, 76, 994-1001.
140. Ortiz-Lucas, M.; Tobías, A.; Saz, P.; Sebastián, J.J. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. Rev. Esp. Enferm. Dig. 2013, 105, 19-36.
141. Chen, P.W.; Jheng, T.T.; Shyu, C.L.; Mao, F.C. Synergistic antibacterial efficacies of the combination of bovine lactoferrin or its hydrolysate with probiotic secretion in curbing the growth of meticillin-resistant Staphylococcus aureus. J. Med. Microbiol. 2013, 62, 1845-1851.
142. Tomaro-Duchesneau, C.; Saha, S.; Malhotra, M.; Jones, M.L.; Labbé, A.; Rodes, L.; Kahouli, I.; Prakash, S. Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: An in vivo analysis using ZDF rats. Appl. Microbiol. Biotechnol. 2014, 98, 115-126.
143. Szajewska, H.; Urbańska, M.; Chmielewska, A.; Weizman, Z.; Shamir, R. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef. Microbes. 2014, doi:10.3920/BM2013.0056.
144. Anabrees, J.; Indrio, F.; Paes, B.; AlFaleh, K. Probiotics for infantile colic: A systematic review. BMC Pediatr. 2013, 13, 186, doi:10.1186/1471-2431-13-186.
145. Indrio, F.; Di Mauro, A.; Riezzo, G.; Civardi, E.; Intini, C.; Corvaglia, L.; Ballardini, E.; Bisceglia, M.; Cinquetti, M.; Brazzoduro, E.; et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: A randomized clinical trial. JAMA Pediatr. 2014, 168, 228-233.
146. Oncel, M.Y.; Sari, F.N.; Arayici, S.; Guzoglu, N.; Erdeve, O.; Uras, N.; Oguz, S.S.; Dilmen, U. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: A randomised controlled trial. Arch. Dis. Child. Fetal Neonatal. Ed. 2013, 99, F110-F115.
147. Jacobs, S.E.; Tobin, J.M.; Opie, G.F.; Donath, S.; Tabrizi, S.N.; Pirotta, M.; Morley, C.J. Garland, S.M; ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: A randomized controlled trial. Pediatrics. 2013, 132, 1055-1062.
148. Li, D.; Rosito, G.; Slagle, T. Probiotics for the prevention of necrotizing enterocolitis in neonates: An 8-year retrospective cohort study. J. Clin. Pharm. Ther. 2013, 38, 445-449.
149. Janvier, A.; Malo, J.; Barrington, K.J. Cohort study of probiotics in a North American neonatal intensive care unit. J. Pediatr. 2014, doi:10.1016/j.jpeds.2013.11.025.
150. Pinto, G.S.; Cenci, M.S.; Azevedo, M.S.; Epifanio, M.; Jones, M.H. Effect of yogurt Containing Bifidobacterium animalis subsp. lactis DN-173010 probiotic on dental plaque and saliva in orthodontic patients. Caries Res. 2014, 48, 63-68.
151. Bordoni, A.; Amaretti, A.; Leonardi, A.; Boschetti, E.; Danesi, F.; Matteuzzi, D.; Roncaglia, L.; Raimondi, S.; Rossi, M. Cholesterol-lowering probiotics: In vitro selection and in vivo testing of bifidobacteria. Appl. Microbiol. Biotechnol. 2013, 9, 8273-8281.
152. West, N.P.; Horn, P.L.; Pyne, D.B.; Gebski, V.J.; Lahtinen, S.J.; Fricker, P.A.; Cripps, A.W. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin. Nutr. 2013, doi:10.1016/j.clnu.2013.10.002.
153. Yu, H.; Liu, L.; Chang, Z.; Wang, S.; Wen, B.; Yin, P.; Liu, D.; Chen, B.; Zhang, J. Genome sequence of the bacterium Bifidobacterium longum strain CMCC P0001, a probiotic strain used for treating gastrointestinal disease. Genome Announc. 2013, doi:10.1128/genomeA.00716-13.
154. Schwarzer, M.; Srutkova, D.; Schabussova, I.; Hudcovic, T.; Akgün, J.; Wiedermann, U.; Kozakova, H. Neonatal colonization of germ-free mice with Bifidobacterium longum prevents allergic sensitization to major birch pollen allergen Bet v 1. Vaccine 2013, 31, 5405-5412.
155. Lee, J.S.; Chung, M.J.; Seo, J.G. In vitro evaluation of antimicrobial activity of lactic acid bacteria against Clostridium difficile. Toxicol. Res. 2013, 29, 99-106.
156. Fernandez, B.; Hammami, R.; Savard, P.; Jean, J.; Fliss, I. Pediococcus acidilactici UL5 and Lactococcus lactis ATCC 11454 are able to survive and express their bacteriocin genes under simulated gastrointestinal conditions. J. Appl. Microbiol. 2013, doi: 10.1111/jam.12391.
157. Raz, I.; Gollop, N.; Polak-Charcon, S.; Schwartz, B. Isolation and characterisation of new putative probiotic bacteria from human colonic flora. Br. J. Nutr. 2007, 97, 725-734.
158. Mehta, R.; Arya, R.; Goyal, K.; Singh, M.; Sharma, A.K. Bio-preservative and therapeutic potential of pediocin: Recent trends and future perspectives. Recent Pat. Biotechnol. 2013, 7, 172-178.
159. Kaur, B.; Garg, N.; Sachdev, A.; Kumar, B. Effect of the oral intake of probiotic Pediococcus acidilactici BA28 on Helicobacter pylori causing peptic ulcer in C57BL/6 mice models. Appl. Biochem. Biotechnol. 2014, 172, 973-983.
160. Benmechernene, Z.; Chentouf, H.F.; Yahia, B.; Fatima, G.; Quintela-Baluja, M.; Calo-Mata, P.; Barros-Velázquez, J. Technological aptitude and applications of Leuconostoc mesenteroides bioactive strains isolated from algerian raw camel milk. Biomed. Res. Int. 2013, 2013, doi:10.1155/2013/418132.
161. Ratna Sudha, M.; Yelikar, K.A.; Deshpande, S. Clinical study of Bacillus coagulans unique IS-2 (ATCC PTA-11748) in the treatment of patients with bacterial vaginosis. Indian J. Microbiol. 2012, 52, 396-399.
162. Benson, K.F.; Redman, K.A.; Carter, S.G.; Keller, D.; Farmer, S.; Endres, J.R.; Jensen, G.S. Probiotic metabolites from Bacillus coagulans GanedenBC30™ support maturation of antigen-presenting cells in vitro. World J. Gastroenterol. 2012, 18, 1875-1883.
163. Jindal, G.; Pandey, R.K.; Agarwal, J.; Singh, M. A comparative evaluation of probiotics on salivary mutans Streptococci counts in Indian children. Eur. Arch. Paediatr. Dent. 2011, 12, 211-215.
164. Clark, L.C.; Hodgkin, J. Commensals, probiotics and pathogens in the Caenorhabditis elegans model. Cell Microbiol. 2014, 16, 27-38.
165. Bereswill, S.; Fischer, A.; Dunay, I.R.; Kühl, A.A.; Göbel, U.B.; Liesenfeld, O.; Heimesaat, M.M. Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis. Eur. J. Microbiol. Immunol. (Bp.) 2013, 3, 126-134.
166. Stein, E.; Inic-Kanada, A.; Belij, S.; Montanaro, J.; Bintner, N.; Schlacher, S.; Mayr, U.B.; Lubitz, W.; Stojanovic, M.; Najdenski, H. et al. In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: Cell-based delivery system to target ocular surface diseases. Invest. Ophthalmol. Vis. Sci. 2013, 54, 6326-6333.
167. Deriu, E.; Liu, J.Z.; Pezeshki, M.; Edwards, R.A.; Ochoa, R.J.; Contreras, H.; Libby, S.J.; Fang, F.C.; Raffatellu, M. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe. 2013, 14, 26-37.
168. Blaser, M.J.; Falkow, S. What are the consequences of the disappearing human microbiota? Nat. Rev. Microbiol. 2009, 12, 887-894.
169. Gelberg, H.B. Comparative anatomy, physiology, and mechanisms of disease production of the esophagus, stomach, and small intestine. Toxicol. Pathol. 2014, 42, 54-66.
170. Pamer, E.G. Fecal microbiota transplantation: Effectiveness, complexities, and lingering concerns. Mucosal Immunol. 2014, doi:10.1038/mi.2013.117.
171. Blaser M. Antibiotic overuse: Stop the killing of beneficial bacteria. Nature 2011, 476, 393-394.
172. Caselli, M.; Cassol, F.; Calò, G.; Holton, J.; Zuliani, G.; Gasbarrini, A. Actual concept of "probiotics": Is it more functional to science or business? World J. Gastroenterol. 2013, 19, 1527-1540.
173. Grover, S.; Rashmi, H.M.; Srivastava, A.K.; Batish, V.K. Probiotics for human health-New innovations and emerging trends. Gut. Pathog. 2012, 4, doi:10.1186/1757-4749-4-15.
174. Boyle, R.J.; Robins-Browne, R.M.; Tang, M.L. Probiotic use in clinical practice: What are the risks? Am. J. Clin. Nutr. 2006, 83, 1256-1264.
175. Snydman, D.R. The safety of probiotics. Clin. Infect. Dis. 2008, 46, S104-S111.